Telomere attrition and Chk2 activation in human heart failure
about
BRCA1 is an essential regulator of heart function and survival following myocardial infarctionOxidative damage in telomeric DNA disrupts recognition by TRF1 and TRF2Role of Telomerase in the Cardiovascular SystemOxidative stress-induced telomeric erosion as a mechanism underlying airborne particulate matter-related cardiovascular diseaseEffects of biological sex on the pathophysiology of the heartTelomere shortening in human diseasesTelomeres and Telomerase in Cardiovascular DiseasesTelomere shortening and metabolic compromise underlie dystrophic cardiomyopathyTelomeres and early-life stress: an overviewTelomerase Is Essential for Zebrafish Heart RegenerationTelomere biology in healthy aging and disease.Unchain my heart: the scientific foundations of cardiac repairChemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA.Aging, telomeres and heart failure.Beyond average: potential for measurement of short telomeres.Telomere biology in cardiovascular disease - role of insulin sensitivity in diabetic hearts.Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regenerationActivation of Rho-associated coiled-coil protein kinase 1 (ROCK-1) by caspase-3 cleavage plays an essential role in cardiac myocyte apoptosisDNA damage checkpoint kinase Chk2 triggers replicative senescence.Telomeres, telomerase, and apoptosis.Death begets failure in the heart.Cardiac stem cells and mechanisms of myocardial regeneration.Telomerase expression in the mammalian heartAbrogation of Age-Induced MicroRNA-195 Rejuvenates the Senescent Mesenchymal Stem Cells by Reactivating Telomerase.Telomere dynamics during aging in polygenic left ventricular hypertrophy.DNA damage accumulation and TRF2 degradation in atypical Werner syndrome fibroblasts with LMNA mutations.Telomeres and mitochondria in the aging heart.Sirt1 protects the heart from aging and stress.Telomerase confers resistance to caspase-mediated apoptosis.Telomere biology in heart failure.Identification of small juvenile stem cells in aged bone marrow and their therapeutic potential for repair of the ischemic heart.Renal dysfunction is associated with shorter telomere length in heart failure.Prevention of heart failure in the elderly: when, where and how to begin?Stem cell therapy for cardiac disease.Age related cardiovascular dysfunction and effects of physical activity.Telomere, aging and age-related diseases.The influence of the telomere-telomerase system on diabetes mellitus and its vascular complications.Evaluation of telomere length in human cardiac tissues using cardiac quantitative FISH.Cardiac telomere length in heart development, function, and disease.Telomere length and psychological well-being in patients with chronic heart failure.
P2860
Q24300290-B65B6768-6E10-46DE-8F71-474F87DA6918Q24793970-ED20DD72-03D8-46FA-9D72-FDC049EE6322Q26744305-A6C383FA-E82A-4FE2-A6D8-426751EFE847Q26859273-D0660DCA-1B45-48AF-9A23-BBDDC35D12B8Q26866520-78E60581-4D6E-4C1A-9F34-733DD2D2AAAFQ27004080-6A5EE24F-D462-4310-8ADD-E4EC72A578CFQ28076220-00B1BD6A-3532-4C90-B84F-D94D2BA80362Q28315028-6CB432C9-BC26-4C4C-B851-E525AAC1D2D3Q28390850-6C6309FC-6A82-4384-9CF0-7EE157E7C21AQ30402189-D7F0374D-B5E8-4C38-BEFA-3988D3A97AE4Q33572237-F3F6C180-0E13-4EC6-9C50-5BFE7C9BB1BDQ33683767-FC389CF8-73FC-4B51-A01A-9D4A16ECAC50Q33814333-301C1825-C762-4792-932D-6B4DE5392E0DQ34058253-2C16D00D-84D4-493F-9083-2657BB8D56D7Q34280216-542AA619-1701-4071-B5BD-6632E2359DEBQ34467089-67159467-36D8-4DDA-8898-5786EE665E0CQ34981422-AA5DEB9E-0285-437D-984A-2CAEDBCE684BQ35080715-9263BFC8-6FDC-4F32-ABF4-26C74A78A470Q35835972-50CEDF69-4B1D-4473-8704-815284653A4DQ35851312-5C025D5F-EAC7-4805-A07A-87C16A2D3074Q36070078-BB233118-8EF1-4514-BE0E-1B60FEB32A3CQ36267790-E91908A6-1539-4BCA-9425-DBB71FDEF465Q36430800-186F47C3-66C8-4064-B35D-CBACDBEF4787Q36701920-ED9A4813-1DBD-41E6-8DB9-0877B30D5FF8Q36904769-BCE8D72F-C2C7-42DB-ABF3-01CC83AB5DF2Q36983606-4899C3A5-0335-4B33-B4CB-7A98293D292DQ37033248-2741C51E-DFB4-4FC7-8980-A4727B917DF3Q37061424-56F6368F-6CBB-4C6E-8327-3E150C792D64Q37224422-AB62FCD3-8109-4C46-84CB-E4F7CDCAD244Q37278711-C382F288-7AD9-47E7-A681-EEA03EE5DE87Q37342074-F81CC894-1D43-480F-9D89-83DF40FF337DQ37363993-EF419CAE-A717-4A30-B286-3FD5A00A34E7Q37978190-31599D26-9C39-4BD7-8B1D-FCD0C5965AF2Q37995019-24D47655-7F5D-4364-BDB5-D3542CE94D99Q38015080-07EB8F6F-2C83-4B1E-AA42-F49E737D3628Q38112327-E17DF7FE-0F66-4E19-8E21-AE1A4B27E444Q38353839-C2BFAA0F-FFD2-427B-9402-1937DC22C6B5Q38372293-10ACA9C3-2784-45DF-8893-583360D90B6BQ38678302-56A3542A-8D3A-47BB-A657-3F4AACE27D24Q39908598-FBF25B1D-D47C-4717-937A-7ADFA849B1BF
P2860
Telomere attrition and Chk2 activation in human heart failure
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Telomere attrition and Chk2 activation in human heart failure
@ast
Telomere attrition and Chk2 activation in human heart failure
@en
Telomere attrition and Chk2 activation in human heart failure
@nl
type
label
Telomere attrition and Chk2 activation in human heart failure
@ast
Telomere attrition and Chk2 activation in human heart failure
@en
Telomere attrition and Chk2 activation in human heart failure
@nl
prefLabel
Telomere attrition and Chk2 activation in human heart failure
@ast
Telomere attrition and Chk2 activation in human heart failure
@en
Telomere attrition and Chk2 activation in human heart failure
@nl
P2093
P2860
P356
P1476
Telomere attrition and Chk2 activation in human heart failure
@en
P2093
Arun Prahash
Christine S Moravec
George E Taffet
Hidemasa Oh
Keith A Youker
Lloyd H Michael
Mark L Entman
Michael D Schneider
Motoaki Sano
Sam C Wang
P2860
P304
P356
10.1073/PNAS.0836098100
P407
P577
2003-04-17T00:00:00Z